Abstract
Chronic inflammatory diseases of the intestine (i.e. Crohn’s and chronic ulcerative colitis-collectively known as inflammatory bowel disease [IBDI) are a very significant public health problem in the United States and other industrialized nations. Thus, effort has been made toward understanding the biological mechanisms that regulate such inflammation. Largely, these efforts have focused on identifying the mechanisms that mediate activation of inflammation and have succeeded in identifying a variety of signaling pathways by which a wide range of agonists can activate a mucosal immune inflammatory response. Playing a central role in many of these pathways is the intestinal epithelium, which serves as a barrier to, and interfaces with the outside world. However, recent studies have shown that not only can some agonists activate pro-inflammatory signals in intestinal epithelial cells, but other agonists can activate “anti-inflammatory” signals in these cells that dampen the responses to pro-inflammatory agonists. One such anti-inflammatory agonist is the eicosanoid lipoxin A4 (LXA4). Specifically, LXA4its epimer 15-LXA4and their analogs potently down-regulate defining and causative events of intestinal inflammation in an in vitro model. These compounds are now being tested for their ability to down-regulate inflammation in mouse models of colitis and may ultimately prove to be of significant benefit to individuals suffering from debilitating chronic inflammatory intestinal disorders.
Keywords
- Inflammatory Bowel Disease
- Intestinal Epithelial Cell
- Intestinal Epithelium
- Intestinal Inflammation
- Stable Analog
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Madara, J. L., T. W. Patapoff, B. Gillece-Castro, S. P. Colgan, C. A. Parkos, C. Delp, and R. J. Mrsny. 1993. 5’-Adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cells. J. Clin. Invest. 91:2320.
Madara, J. L., C. A. Parkos, S. P. Colgan, R. J. MacLeod, S. Nash, J. Matthews, C. Delp, and W. S. Lencer. 1992. CF secretion in a model intestinal epithelium induced by a neutrophil - derived secretagogue. J. Clin. Invest. 89:1938.
Madara, J. L., S. Nash, and C. Parkos. 1991. Neutrophil-Epithelial Cell Interactions in the Intestine. Plenum Press.
Madara, J. 1989. Loosening TJs. Lessons from the intestine. J. Clin. Invest. 83:1089.
McCormick, B., A. Gewirtz, and J. L. Madara. 1998. Epithelial crosstalk with bacteria and immune cells. Curr. Opin. Gastro. 14:492.
Baumgart, D. C., L. D. McVay, and S. R. Carding. 1998. Mechanisms of immune cell-mediated tissue injury in inflammatory bowel diseaselnt J Mol Med 1:315.
Jung, H. C., L. Eckmann, Y. S-K., A. Panja, J. Fierer, E. Morzycka-Wroblewska, and M. F. Kagnoff. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95:55.
McCormick, B. A., S.P. Colgan, C.D. Archer, S.I. Miller, J.L. Madara. 1993. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J. Cell. Biol. 123:895.
McCormick, B., P. Hofman, J. Kim, D. Carnes, S. Miller, and J. Madara. 1995. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J. Cell. Biol. 131:1599.
McCormick, B. A., C. A. Parkos, S. P. Colgan, D. K. Carnes, and J. L. Madara. 1998. Apical secretion of a pathogen-elicited epithelial chemoattractant (PEEC) activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium. J. Immunol. 160:455.
Daig, R., T. Andus, E. Aschenbrenner, W. Falk, J. Scholmerich, and V. Gross. 1996. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38:216.
Funakoshi, K., K. Sugimura, T. Sasakawa, H. Bannai, K. Anezaki, K. Ishizuka, K. Yoshida, R. Narisawa, and H. Asakura. 1995. Study of cytokines in ulcerative colitis. J Gastroenterol 30 Suppl 8:61.
Mazzucchelli, L., C. Hauser, K. Zgraggen, H. Wagner, M. Hess, J. A. Laissue, and C. Mueller. 1994. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 144:997.
Nielsen, O. H., N. Rudiger, M. Gaustadnes, and T. Horn. 1997. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Scand J Gastroenterol 32:1028.
Gewirtz, A. T., A. S. Rao, P. O. Simon, Jr., D. Merlin, D. Carnes, J. L. Madara, and A. S. Neish. 2000. Salmonella typhimurium induces epithelial IL-8 expression via Ca(2+)- mediated activation of the NFkappaB pathway. J Clin Invest 105:79.
Kagnoff, M. F. 1988. Immunology of Digestive system. Raven Press, New York.
Serhan, C. N. 1997. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): A jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53:107.
Serhan, C. N., J. F. Maddox, N. A. Petasis, I. Akritopoulou-Zanze, A. Papayianni, H. R. Brady, S. P. Colgan, and J. L. Madara. 1995. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34:14609.
Claria, J., and C. N. Serhan. 1995. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA 92:9475.
Fiore, S., M. Romano, E. Reardon, and C. N. Serhan. 1993. Induction of functional lipoxin A4 receptors in HL-60 cells. Blood 81:3395.
Gronert, K. G., A. T. Gewirtz, J. L. Madara, and C. N. Serhan. 1998. Identification of a human enterocyte lipoxin A4 receptor that is regulated by IL-13 and INF-y that inhibits TNF-a-induced IL-8 release. J. Exp. Med. 187:1285.
Lee, T. H., C. E. Horton, U. Kyan-Aung, D. Haskard, A. E. Crea, and B. W. Spur. 1989. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and Nformyl-L-methionyl-L-Ieucyl-L-phenylalanine. Clin. Sci. 77:195.
Colgan, S. P., C. N. Serhan, C. A. Parkos, C. Delp-Archer, and J. L. Madara. 1993. Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92:75.
Gewirtz, A. T., B. McCormick, A. S. Neish, N. A. Petasis, K. Gronert, C. N. Serhan, and J. L. Madara. 1998. Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. J Clin Invest 101:1860.
Gewirtz, A. T., V. V. Fokin, N. A. Petasis, C. N. Serhan, and J. L. Madara. 1999. LXA4, aspirin-triggered15-epi LXA4, and their stable analogs electively down-regulate PMN azurophilic degranulation. Am J.Phys. (Cell) 276 C988–C994
Fiore, S., J. F. Maddox, H. D. Perez, and C. N. Serhan. 1994. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exper. Med. 180:253.
Gomez-Cambronero, J., and P. Keire. 1998. Phospholipase D: a novel major player in signal transduction. Cell Signal 10:387.
Gewirtz, A. T., and E. R. Simons. 1997. Phospholipase D mediates Fc receptor activation of neutrophils and provides signaling specificity between signaling pathways activated by fMLP and HIC. J. Leuk. Biol. 61:131.
Levy, B. D., V. V. Fokin, J. M. Clark, M. J. Wakelam, N. A. Petasis, and C. N. Serhan. 1999. Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a ‘stop’ signaling switch for aspirin-triggered Iipoxin A4. Faseb J 13:903.
Goh, J., Baird, A.W., Goodson, C. 1999. Stable lipoxin analogs attenuate chemokine release from cytokine activated human colonic epithelium. Gastroenterology 116:(4) A724.
Raud, J., U. Palmertz, S. E. Dahlen, and P. Hedqvist. 1991. Lipoxins inhibit microvascular inflammatory actions of leukotriene B4. Adv. Exper. Med. Biol. 314:185.
Takano, T., S. Fiore, J. F. Maddox, H. R. Brady, N. A. Petasis, and C. N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A4 and LXA4 stable anaolgs are potent inhibitors of accute inflammation: Evidence for anti-inflammatory receptors. J. Exp. Med 185:1693.
Hawkey, C. J. 1996. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment. Scand J Gastroenterol Suppl 220:124.
Reuter, B. K., S. Asfaha, A. Buret, K. A. Sharkey, and J. L. Wallace. 1996. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 98:2076.
Wallace, J. L., B. K. Reuter, W. McKnight, and A. Bak. 1998. Selective inhibitors of cyclooxygenase-2: are they really effective, selective, and GI-safe? [In Process Citation]. J Clin Gastroenterol 27:S28.
Wallace, J. L., A. Bak, W. McKnight, S. Asfaha, K. A. Sharkey, and W. K. MacNaughton. 1998. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology 115.101.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gewirtz, A.T., Neish, A.S., Madara, J.L. (2002). Mechanisms of Active Intestinal Inflammation and Potential Down-Regulation Via Lipoxins. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E., Serhan, C. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 5. Advances in Experimental Medicine and Biology, vol 507. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0193-0_35
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0193-0_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4960-0
Online ISBN: 978-1-4615-0193-0
eBook Packages: Springer Book Archive